FDA OK's first antibody drug intended for long-term COVID-19 prevention
CBSN
Washington — Federal health officials on Wednesday authorized a new COVID-19 antibody drug for people with serious health problems or allergies who can't get adequate protection from vaccination.
Antibody drugs have been a standard treatment for treating COVID-19 infections for over a year. But the AstraZeneca antibody drug cleared by the Food and Drug Administration is different. It's the first intended for long-term prevention against COVID-19 infection, rather than a short-term treatment.
People who could benefit from the antibody drug include cancer patients, organ transplant recipients and people taking immune-suppressing drugs for conditions like rheumatoid arthritis. Health experts estimate about 2% to 3% of the U.S. population falls into that group.
On May 7, health influencer Paul Saladino, M.D.. posted a video to his X account that promoted feeding "raw dairy" to infants. The post received over 90,000 views and sparked strong backlash before it was removed the following day. Saladino regularly advocates for "animal-based" diets featuring raw milk, including on his TikTok channel where he has over half a million followers.
Everywhere you look, things are getting more complicated. Our phones have over a thousand settings. Showerheads come with apps. Cars have touchscreens. Ovens have touchscreens. "There's no doubt that 'featuritis' is real," said design consultant Jakob Nielsen. "Most of these things are too complicated."
New research is adding to the evidence linking ultra-processed foods to health concerns. The study tracked people's habits over 30 years and found those who reported eating more of certain ultra-processed foods had a slightly higher risk of death — with four categories of foods found to be the biggest culprits.